|
ISOC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
1.09134923320653E-13 |
| Normal-vs-Stage3 |
1.25409682638633E-11 |
| Normal-vs-Stage4 |
2.89089999716552E-08 |
| Stage1-vs-Stage2 |
9.421200E-01 |
| Stage1-vs-Stage3 |
2.321800E-01 |
| Stage1-vs-Stage4 |
5.506000E-01 |
| Stage2-vs-Stage3 |
3.280400E-01 |
| Stage2-vs-Stage4 |
5.250600E-01 |
| Stage3-vs-Stage4 |
8.651800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
1.433720E-04 |
| Caucasian-vs-AfricanAmerican |
7.958800E-01 |
| Caucasian-vs-Asian |
3.228000E-01 |
| AfricanAmerican-vs-Asian |
3.550800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
4.896100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.62436730732907E-12 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
2.22044604925031E-16 |
| Normal-vs-Extreme_Obese |
1.64540000002766E-06 |
| Normal_Weight-vs-Extreme_Weight |
6.560200E-01 |
| Normal_Weight-vs-Obese |
7.472400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.351800E-01 |
| Extreme_Weight-vs-Obese |
4.150000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.601000E-01 |
| Obese-vs-Extreme_Obese |
3.695400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.68119962395963E-11 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
7.79549980123306E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.338600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.980800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.179600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.344000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.393400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.282200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.25710553078306E-12 |
| Normal-VS-KIRP CIMP |
1.23234755733392E-14 |
| Normal-VS-Unclassified PRCC |
1.62447832963153E-12 |
| Type1 PRCC-VS-Type2 PRCC |
6.14919999999408E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.699620E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.002000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.006280E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.462700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.268390E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-15 |
| Normal-vs-N1 |
1.03419495189883E-11 |
| Normal-vs-N2 |
1.433840E-04 |
| N0-vs-N1 |
6.180600E-01 |
| N0-vs-N2 |
9.924800E-01 |
| N1-vs-N2 |
8.215600E-01 |
|
|
